BiomX Inc. COmmon Stock (PHGE)

About PHGE

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

20

Website

www.biomx.com/

Fundamentals

1-day range

$0.1301$0.1495

Market cap

$4.62M

P/E (trailing)

—

P/E (forward)

-0.02

EPS (trailing)

$-24.74

Dividend yield

—

Beta

1.31

Avg. volume

2.79M

BiomX Inc. COmmon Stock Competitors

Chosen by industry and closest market cap.

• PHGE

  BiomX Inc. COmmon Stock

  $0.138

  ▲ 4.55%
  Market cap $4.62MP/E —
  $0.1192$12.29
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $4.03MP/E —
  $0.2625$5.3
• BCAB

  BioAtla Inc. Common Stock

  $1.79

  ▼ 42.99%
  Market cap $5.41MP/E —
  $2.81$71.5
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.32MP/E —
  $0.1901$2.89
• SCNI

  Scinai Immunotherapeutics Ltd. American Depositary Shares

  $2.53

  ▼ 5.60%
  Market cap $1.37MP/E 0.14
  $2.15$16.8
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $9.45MP/E —
  $0.75$2.29
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $10.04MP/E —
  $1.4$39

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• BiomX Announces 1-For-10 Reverse Stock Split Of Common Stock
  benzinga · 8/28/2026
• BiomX Announces 1-For-10 Reverse Stock Split Of Common Stock
  Benzinga · 8/28/2026
• BiomX’s Subsidiary, Zorronet, Bags ~$300K Order For Planning, Integration And Deployment Of Unified Operational Environment At Defense Technology Test And Evaluation Site
  Benzinga · 8/14/2026

• Reuven Yeganeh · March 17, 2026 · Conversion

  1.1K
• Reuven Yeganeh · March 17, 2026 · Sale

  530.0K @ $5
• Reuven Yeganeh · March 17, 2026 · Conversion

  530.0K @ $2
• Reuven Yeganeh · March 16, 2026 · Sale

  1.70M @ $4.76
• Reuven Yeganeh · March 16, 2026 · Sale

  2.00M @ $5.24
• Reuven Yeganeh · March 16, 2026 · Sale

  1.30M @ $5
• Reuven Yeganeh · March 16, 2026 · Conversion

  900
• Reuven Yeganeh · March 16, 2026 · Sale

  450.0K @ $5
• Reuven Yeganeh · March 16, 2026 · Conversion

  450.0K @ $2
• Reuven Yeganeh · March 13, 2026 · Conversion

  740
• Reuven Yeganeh · March 13, 2026 · Sale

  370.0K @ $5
• Reuven Yeganeh · March 13, 2026 · Conversion

  370.0K @ $2
• Reuven Yeganeh · March 12, 2026 · Conversion

  600
• Reuven Yeganeh · March 12, 2026 · Sale

  300.0K @ $5
• Reuven Yeganeh · March 11, 2026 · Conversion

  300.0K @ $2

Institutional Ownership

March 31, 2026

Total shares held

298.8K

Total value held

$1.12M

Institutional holders

12